Foxp3+CD25+CD4+ Tregs play an essential role as lung-protective immunomodulators in ALI following MSC treatment, acting through IL-10 on several cytokine-dependent and cellular inflammatory targets (171, 221, 222). Here, FOXP3 is linked to acute respiratory distress syndrome.